|Articles|February 15, 2022
Supplements and Featured Publications
- Current Landscape of Treatment Options for Patients With Amyotrophic Lateral Sclerosis (ALS)
Current Landscape of Treatment Options for Patients With Amyotrophic Lateral Sclerosis (ALS)
Advertisement
Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disease that has no established cure and is frequently fatal within 2 to 5 years as patients experience a rapid functional decline in their abilities to move, talk, swallow, and breathe. Current treatment options remain limited, but there is a pipeline of late-stage therapeutic options that could expand the treatment options for patients with ALS.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer
2
Enfortumab Vedotin Plus Pembro Cuts Risk of Disease Progression, Death 60% for Patients With MIBC Who Can’t Have Chemo With Bladder Removal
3
New Biomarkers, Drug Targets Identified for Colorectal Cancer
4
First-Line Zongertinib Yields Strong Responses in Patients With Advanced HER2-Mutant NSCLC
5